Key Insights

Highlights

Success Rate

91% trial completion (above average)

Published Results

13 trials with published results (9%)

Research Maturity

84 completed trials (55% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

5.3%

8 terminated out of 152 trials

Success Rate

91.3%

+4.8% vs benchmark

Late-Stage Pipeline

9%

14 trials in Phase 3/4

Results Transparency

15%

13 of 84 completed with results

Key Signals

13 with results91% success

Data Visualizations

Phase Distribution

84Total
Not Applicable (50)
Early P 1 (2)
P 1 (12)
P 2 (6)
P 3 (9)
P 4 (5)

Trial Status

Completed84
Recruiting19
Unknown17
Not Yet Recruiting10
Terminated8
Active Not Recruiting8

Trial Success Rate

91.3%

Benchmark: 86.5%

Based on 84 completed trials

Clinical Trials (152)

Showing 20 of 20 trials
NCT05695391Phase 3TerminatedPrimary

Safety and Efficacy of FVIIa to Prevent Excessive Bleeding in Hemophilia Patients With Inhibitors Undergoing Major Surgery

NCT06345833Early Phase 1WithdrawnPrimary

Topical and Local TXA in Facelifts - A Randomized Controlled Double Blinded Study

NCT04278404Recruiting

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

NCT04398628Recruiting

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

NCT07691437Not ApplicableCompleted

Effect of Non-Surgical Periodontal Treatment on Oral Health in Hemophilia Patients

NCT07682519Not ApplicableRecruitingPrimary

Multimodal Telerehabilitation Versus Face-to-Face Care for Adults With Hemophilia and Chronic Pain

NCT07187661Not ApplicableCompletedPrimary

Intra-Articular Bevacizumab for Preventing Recurrent Hemarthrosis in Hemophilia With Chronic Synovitis

NCT07285460Phase 3RecruitingPrimary

A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B

NCT03974113Phase 2Active Not RecruitingPrimary

Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B

NCT04384341Not ApplicableCompletedPrimary

Haemophilia and Bone Loss - PHILEOS Study

NCT05202951Active Not Recruiting

Chronic Pain and Hemophilia

NCT06580340Not ApplicableCompletedPrimary

Effectiveness of an Adapted Physical Activity Program for Subjects Suffering From Haemophilia

NCT06543368Not ApplicableCompleted

Low-Cost Platelet-Rich Plasma for Hemarthropathy

NCT07579585Not ApplicableRecruiting

Effects of Photobiomodulation in Hemophilia Patients.

NCT06752850Phase 4Active Not Recruiting

A Study to Investigate the Course of Synovial Hypertrophy in Patients With Haemophilia A on Efanesoctocog Alfa Prophylaxis

NCT06992076RecruitingPrimary

Adult and Adolescent Hemophilia Patients Treated With Marstacimab: a Patient Experience Registry

NCT06191068CompletedPrimary

Canadian CHO-KLAT/H-FIT Study - Quality of Life of, and Burden of Caring for, Persons With Hemophilia

NCT06922045Phase 3RecruitingPrimary

Phase III Clinical Trial of STSP-0601 for Injection in Hemophilia Patients

NCT06820515RecruitingPrimary

ATHNdataset Registry

NCT07516730Not Yet RecruitingPrimary

Central Pain Mechanisms and Clinical and Psychological Factors Associated With Pain Interference in Daily Life in Adults With Hemophilia and Hemophilic Arthropathy

Scroll to load more

Research Network

Activity Timeline